US5326570A
(en)
*
|
1991-07-23 |
1994-07-05 |
Pharmavene, Inc. |
Advanced drug delivery system and method of treating psychiatric, neurological and other disorders with carbamazepine
|
FR2702148B1
(fr)
*
|
1993-03-05 |
1995-04-07 |
Rhone Poulenc Rorer Sa |
Application d'anticonvulsivants dans le traitement du neuro-sida.
|
US6440457B1
(en)
*
|
1993-05-27 |
2002-08-27 |
Alza Corporation |
Method of administering antidepressant dosage form
|
EP0711166A1
(en)
*
|
1993-07-22 |
1996-05-15 |
Warner-Lambert Company |
Controlled release tacrine drug delivery systems and methods for preparing same
|
US5472714A
(en)
*
|
1993-09-08 |
1995-12-05 |
Ciba-Geigy Corporation |
Double-layered oxcarbazepine tablets
|
DE69535127T2
(de)
*
|
1994-03-18 |
2007-02-15 |
Supernus Pharmaceuticals, Inc. |
Emulgierte arzneistoffabgabesysteme
|
US5536507A
(en)
*
|
1994-06-24 |
1996-07-16 |
Bristol-Myers Squibb Company |
Colonic drug delivery system
|
US5534263A
(en)
*
|
1995-02-24 |
1996-07-09 |
Alza Corporation |
Active agent dosage form comprising a matrix and at least two insoluble bands
|
US5698210A
(en)
|
1995-03-17 |
1997-12-16 |
Lee County Mosquito Control District |
Controlled delivery compositions and processes for treating organisms in a column of water or on land
|
TW487582B
(en)
*
|
1995-08-11 |
2002-05-21 |
Nissan Chemical Ind Ltd |
Method for converting sparingly water-soluble medical substance to amorphous state
|
US5837284A
(en)
*
|
1995-12-04 |
1998-11-17 |
Mehta; Atul M. |
Delivery of multiple doses of medications
|
US5922736A
(en)
*
|
1995-12-04 |
1999-07-13 |
Celegene Corporation |
Chronic, bolus administration of D-threo methylphenidate
|
US6486177B2
(en)
*
|
1995-12-04 |
2002-11-26 |
Celgene Corporation |
Methods for treatment of cognitive and menopausal disorders with D-threo methylphenidate
|
US6479074B2
(en)
|
1996-10-24 |
2002-11-12 |
Pharmaceutical Applications Associates Llc |
Methods and transdermal compositions for pain relief
|
US6572880B2
(en)
|
1996-10-24 |
2003-06-03 |
Pharmaceutical Applications Associates Llc |
Methods and transdermal compositions for pain relief
|
US6290986B1
(en)
|
1996-10-24 |
2001-09-18 |
Pharmaceutical Applications Associates, Llc |
Method and composition for transdermal administration of pharmacologic agents
|
US6919373B1
(en)
*
|
1996-11-12 |
2005-07-19 |
Alza Corporation |
Methods and devices for providing prolonged drug therapy
|
JP2001507359A
(ja)
*
|
1997-01-03 |
2001-06-05 |
エラン コーポレーション ピーエルシー |
徐放性シサプリドミニ錠剤製剤
|
US5848966A
(en)
*
|
1997-03-04 |
1998-12-15 |
Graphic Controls Corporation |
Medical device easily removed from skin and a method of removal therefrom
|
CA2216215A1
(en)
*
|
1997-04-05 |
1998-10-05 |
Isa Odidi |
Controlled release formulations using intelligent polymers having opposing wettability characteristics of hydrophobicity and hydrophilicity
|
US6962997B1
(en)
*
|
1997-05-22 |
2005-11-08 |
Celgene Corporation |
Process and intermediates for resolving piperidyl acetamide steroisomers
|
DE19724696A1
(de)
*
|
1997-06-12 |
1998-12-24 |
Hexal Ag |
Pharmazeutische Zubereitung mit drei Pelletarten
|
AU5155198A
(en)
*
|
1997-08-28 |
1999-03-22 |
Robert Murdock |
Method and composition for transdermal administration of pharmacologic agent
|
FR2771292B1
(fr)
*
|
1997-11-21 |
2000-02-18 |
Ethypharm Lab Prod Ethiques |
Spheroides contenant de la tiagabine, procede de preparation et compositions pharmaceutiques
|
DE19809719A1
(de)
*
|
1998-03-06 |
1999-09-09 |
Roehm Gmbh |
Wäßrige Dispersion geeignet zur Herstellung von Überzugs- und Bindemitteln für feste orale Arzneiformen
|
US6211194B1
(en)
*
|
1998-04-30 |
2001-04-03 |
Duke University |
Solution containing nicotine
|
US6365183B1
(en)
*
|
1998-05-07 |
2002-04-02 |
Alza Corporation |
Method of fabricating a banded prolonged release active agent dosage form
|
UA69413C2
(uk)
*
|
1998-05-22 |
2004-09-15 |
Брістол-Майерс Сквібб Компані |
Фармацевтична композиція, яка містить серцевину та ентеросолюбільну оболонку, фармацевтична композиція у вигляді сфероїдальних гранул, спосіб одержання сфероїдальних гранул та спосіб одержання фармацевтичної композиції
|
US7122207B2
(en)
|
1998-05-22 |
2006-10-17 |
Bristol-Myers Squibb Company |
High drug load acid labile pharmaceutical composition
|
UA73092C2
(uk)
*
|
1998-07-17 |
2005-06-15 |
Брістол-Майерс Сквібб Компані |
Таблетка з ентеросолюбільним покриттям і спосіб її приготування
|
US6706282B1
(en)
*
|
1998-11-02 |
2004-03-16 |
Evangeline Cruz |
Controlled delivery of phenoxyethyl-substituted 1,2,4-triazolones
|
US6419960B1
(en)
|
1998-12-17 |
2002-07-16 |
Euro-Celtique S.A. |
Controlled release formulations having rapid onset and rapid decline of effective plasma drug concentrations
|
US7083808B2
(en)
*
|
1998-12-17 |
2006-08-01 |
Euro-Celtique S.A. |
Controlled/modified release oral methylphenidate formulations
|
US6673367B1
(en)
|
1998-12-17 |
2004-01-06 |
Euro-Celtique, S.A. |
Controlled/modified release oral methylphenidate formulations
|
US6162466A
(en)
*
|
1999-04-15 |
2000-12-19 |
Taro Pharmaceutical Industries Ltd. |
Sustained release formulation of carbamazepine
|
CA2380333A1
(en)
*
|
1999-08-26 |
2001-03-01 |
Christian Andina |
Pharmaceutical formulations
|
US6544555B2
(en)
|
2000-02-24 |
2003-04-08 |
Advancis Pharmaceutical Corp. |
Antibiotic product, use and formulation thereof
|
AU3986901A
(en)
*
|
2000-02-24 |
2001-09-03 |
Advancis Pharmaceutical Corp |
Antibiotic composition with inhibitor
|
CA2400784C
(en)
*
|
2000-02-24 |
2009-05-19 |
Advanced Pharma, Inc. |
Therapeutic product, use and formulation thereof
|
AU2001239841B2
(en)
*
|
2000-02-24 |
2006-04-27 |
Shionogi, Inc. |
Antibiotic and antifungal compositions
|
US7025989B2
(en)
*
|
2000-02-24 |
2006-04-11 |
Advancis Pharmaceutical Corp. |
Multiple-delayed released antibiotic product, use and formulation thereof
|
US6991807B2
(en)
*
|
2000-02-24 |
2006-01-31 |
Advancis Pharmaceutical, Corp. |
Antibiotic composition
|
AR030557A1
(es)
|
2000-04-14 |
2003-08-27 |
Jagotec Ag |
Una tableta en multicapa de liberacion controlada y metodo de tratamiento
|
US20040122090A1
(en)
*
|
2001-12-07 |
2004-06-24 |
Lipton Stuart A. |
Methods for treating neuropsychiatric disorders with nmda receptor antagonists
|
US6524617B1
(en)
*
|
2001-07-25 |
2003-02-25 |
Isp Investments Inc. |
Synergistic filler composition
|
US7838026B2
(en)
|
2001-09-28 |
2010-11-23 |
Mcneil-Ppc, Inc. |
Burst-release polymer composition and dosage forms comprising the same
|
US20030228368A1
(en)
*
|
2001-09-28 |
2003-12-11 |
David Wynn |
Edible solid composition and dosage form
|
US20040253312A1
(en)
*
|
2001-09-28 |
2004-12-16 |
Sowden Harry S. |
Immediate release dosage form comprising shell having openings therein
|
US20040146559A1
(en)
*
|
2002-09-28 |
2004-07-29 |
Sowden Harry S. |
Dosage forms having an inner core and outer shell with different shapes
|
US6837696B2
(en)
*
|
2001-09-28 |
2005-01-04 |
Mcneil-Ppc, Inc. |
Apparatus for manufacturing dosage forms
|
US7122143B2
(en)
|
2001-09-28 |
2006-10-17 |
Mcneil-Ppc, Inc. |
Methods for manufacturing dosage forms
|
US20040213848A1
(en)
*
|
2001-09-28 |
2004-10-28 |
Shun-Por Li |
Modified release dosage forms
|
US6635675B2
(en)
|
2001-11-05 |
2003-10-21 |
Cypress Bioscience, Inc. |
Method of treating chronic fatigue syndrome
|
US6602911B2
(en)
*
|
2001-11-05 |
2003-08-05 |
Cypress Bioscience, Inc. |
Methods of treating fibromyalgia
|
US6572889B1
(en)
*
|
2002-03-07 |
2003-06-03 |
Noveon Ip Holdings Corp. |
Controlled release solid dosage carbamazepine formulations
|
EP1487414A4
(en)
*
|
2002-03-07 |
2007-12-12 |
Advancis Pharmaceutical Corp |
ANTIBIOTIC COMPOSITION
|
US20040028729A1
(en)
*
|
2002-04-29 |
2004-02-12 |
Shojaei Amir H. |
Pharmaceutical formulations with improved bioavailability
|
AU2003240654A1
(en)
*
|
2002-05-31 |
2003-12-19 |
Desitin Arzneimittel Gmbh |
Pharmaceutical composition containing oxcarbazepine and having a controlled active substance release
|
US7939102B2
(en)
*
|
2002-06-07 |
2011-05-10 |
Torrent Pharmaceuticals Ltd. |
Controlled release formulation of lamotrigine
|
US20040006072A1
(en)
*
|
2002-06-25 |
2004-01-08 |
Franz Robert M. |
Sustained-release alprazolam composition
|
US20040033251A1
(en)
*
|
2002-08-13 |
2004-02-19 |
Medtronic, Inc. |
Active agent delivery system including a polyurethane, medical device, and method
|
JP2006502136A
(ja)
*
|
2002-08-13 |
2006-01-19 |
メドトロニック・インコーポレーテッド |
親水性ポリマーと、医療用デバイスと、そして方法とを含む活性剤送達システム
|
WO2004014450A1
(en)
*
|
2002-08-13 |
2004-02-19 |
Medtronic, Inc. |
Active agent delivery system including a hydrophobic cellulose derivate
|
WO2004014453A1
(en)
*
|
2002-08-13 |
2004-02-19 |
Medtronic, Inc |
Medical device exhibiting improved adhesion between polymeric coating and substrate
|
CA2495172A1
(en)
*
|
2002-08-13 |
2004-02-19 |
Medtronic, Inc. |
Active agent delivery systems, medical devices, and methods
|
US7807197B2
(en)
*
|
2002-09-28 |
2010-10-05 |
Mcneil-Ppc, Inc. |
Composite dosage forms having an inlaid portion
|
MY148805A
(en)
*
|
2002-10-16 |
2013-05-31 |
Takeda Pharmaceutical |
Controlled release preparation
|
NO346973B1
(en)
*
|
2002-12-20 |
2023-03-20 |
Niconovum Ab |
A physically and chemically stable nicotine-containing particulate material
|
JP3811127B2
(ja)
*
|
2003-01-30 |
2006-08-16 |
株式会社東芝 |
情報記録装置及び情報記録方法
|
EP1648407A4
(en)
*
|
2003-07-21 |
2011-08-31 |
Middlebrook Pharmaceuticals Inc |
ANTIBIOTIC PRODUCT, CORRESPONDING USE AND FORMULATION
|
JP2006528189A
(ja)
*
|
2003-07-21 |
2006-12-14 |
アドバンシス ファーマスーティカル コーポレイション |
抗生物質産物、その使用法および製剤
|
US8425936B2
(en)
*
|
2003-07-21 |
2013-04-23 |
Shionogi Inc. |
Antibiotic product, use and formulation thereof
|
US8062672B2
(en)
*
|
2003-08-12 |
2011-11-22 |
Shionogi Inc. |
Antibiotic product, use and formulation thereof
|
CA2535345A1
(en)
*
|
2003-08-13 |
2005-03-03 |
Medtronic, Inc. |
Active agent delivery systems including a miscible polymer blend, medical devices, and methods
|
WO2005023184A2
(en)
*
|
2003-08-29 |
2005-03-17 |
Advancis Pharmaceuticals Corporation |
Antibiotic product, use and formulation thereof
|
JP2007505129A
(ja)
*
|
2003-09-11 |
2007-03-08 |
グリュコン テクノロジーズ グループ エルエルシー |
(−)−ヒドロキシクエン酸の腸溶性送達物
|
US8460710B2
(en)
*
|
2003-09-15 |
2013-06-11 |
Shionogi, Inc. |
Antibiotic product, use and formulation thereof
|
US20050069590A1
(en)
*
|
2003-09-30 |
2005-03-31 |
Buehler Gail K. |
Stable suspensions for medicinal dosages
|
US20050074514A1
(en)
*
|
2003-10-02 |
2005-04-07 |
Anderson Oliver B. |
Zero cycle molding systems, methods and apparatuses for manufacturing dosage forms
|
EP1679066A4
(en)
*
|
2003-10-27 |
2011-06-22 |
Astellas Pharma Inc |
MEDICINAL COATING MICROPARTICLES FOR A MOUTH-DISABLE TABLET
|
WO2005046663A1
(en)
|
2003-11-04 |
2005-05-26 |
Shire Laboratories, Inc. |
Compositions of quaternary ammonium containing bioavailability enhancers
|
EP1680110B1
(en)
|
2003-11-04 |
2011-01-05 |
Supernus Pharmaceuticals, Inc. |
Once daily dosage forms of trospium
|
US20050175695A1
(en)
*
|
2003-11-25 |
2005-08-11 |
Catherine Castan |
Carvedilol free base, salts, anhydrous forms or solvates thereof, corresponding pharmaceutical compositions, controlled release formulations, and treatment or delivery methods
|
CA2452588C
(en)
*
|
2003-12-08 |
2015-05-19 |
Shire Pharmaceutical Development Inc. |
Methods for the treatment of bipolar disorder using carbamazepine
|
US20060094709A1
(en)
*
|
2003-12-08 |
2006-05-04 |
Kalali Amir H |
Methods for the treatment of bipolar disorder using carbamazepine
|
US20050142203A1
(en)
*
|
2003-12-30 |
2005-06-30 |
Grant Heinicke |
Oral dosage formulations of active pharmaceutical ingredients and methods of preparing the same
|
US8067029B2
(en)
|
2004-01-13 |
2011-11-29 |
Mcneil-Ppc, Inc. |
Rapidly disintegrating gelatinous coated tablets
|
US7879354B2
(en)
|
2004-01-13 |
2011-02-01 |
Mcneil-Ppc, Inc. |
Rapidly disintegrating gelatinous coated tablets
|
KR20060124731A
(ko)
*
|
2004-01-29 |
2006-12-05 |
뉴로몰레큘라 파마슈티칼스, 인코포레이티드 |
중추신경계-관련 질환 치료용 nmda 수용체 길항제 및mao-억제제 또는 gadph-억제제의 배합물
|
US20050196446A1
(en)
*
|
2004-03-05 |
2005-09-08 |
Huang Hai Y. |
Polymeric compositions and dosage forms comprising the same
|
US20050196447A1
(en)
*
|
2004-03-05 |
2005-09-08 |
Huang Hai Y. |
Polymeric compositions and dosage forms comprising the same
|
US20050196448A1
(en)
*
|
2004-03-05 |
2005-09-08 |
Hai Yong Huang |
Polymeric compositions and dosage forms comprising the same
|
US20050196442A1
(en)
*
|
2004-03-05 |
2005-09-08 |
Huang Hai Y. |
Polymeric compositions and dosage forms comprising the same
|
US20050239830A1
(en)
*
|
2004-04-26 |
2005-10-27 |
Vikram Khetani |
Methods of diminishing co-abuse potential
|
US8383159B2
(en)
*
|
2004-10-27 |
2013-02-26 |
Mcneil-Ppc, Inc. |
Dosage forms having a microreliefed surface and methods and apparatus for their production
|
US20060088586A1
(en)
*
|
2004-10-27 |
2006-04-27 |
Bunick Frank J |
Dosage forms having a microreliefed surface and methods and apparatus for their production
|
US20060087051A1
(en)
*
|
2004-10-27 |
2006-04-27 |
Bunick Frank J |
Dosage forms having a microreliefed surface and methods and apparatus for their production
|
US20070281022A1
(en)
*
|
2004-10-27 |
2007-12-06 |
Bunick Frank J |
Dosage forms having a microreliefed surface and methods and apparatus for their production
|
US20070190133A1
(en)
*
|
2004-10-27 |
2007-08-16 |
Bunick Frank J |
Dosage forms having a microreliefed surface and methods and apparatus for their production
|
US20060088587A1
(en)
*
|
2004-10-27 |
2006-04-27 |
Bunick Frank J |
Dosage forms having a microreliefed surface and methods and apparatus for their production
|
US20060088593A1
(en)
*
|
2004-10-27 |
2006-04-27 |
Bunick Frank J |
Dosage forms having a microreliefed surface and methods and apparatus for their production
|
DE05852057T1
(de)
|
2004-11-23 |
2007-11-29 |
Neuromolecular Pharmaceuticals Inc., Emeryville |
Zusammensetzung aus einer beschichtung oder matrix mit verzögerter freisetzung und einem nmda-rezeptorantagonisten sowie verfahren zur verabreichung eines solchen nmda-rezeptorantagonisten an ein subjekt
|
US7619007B2
(en)
|
2004-11-23 |
2009-11-17 |
Adamas Pharmaceuticals, Inc. |
Method and composition for administering an NMDA receptor antagonist to a subject
|
WO2006058236A2
(en)
*
|
2004-11-24 |
2006-06-01 |
Neuromolecular Pharmaceuticals, Inc. |
Composition comprising an nmda receptor antagonist and levodopa and use thereof for treating neurological disease
|
BRPI0517166A
(pt)
*
|
2004-12-09 |
2008-09-30 |
Celgene Corp |
uso de d-treo-metilfenidato ou um sal do mesmo
|
CN101132780A
(zh)
*
|
2005-02-15 |
2008-02-27 |
爵士制药公司 |
缓慢释放取代的吡嗪化合物的剂型和方法
|
US20090169619A1
(en)
*
|
2005-02-25 |
2009-07-02 |
Corepharma Llc |
Carbamazepine extended release dosage form
|
AU2006244297A1
(en)
|
2005-04-06 |
2006-11-16 |
Adamas Pharmaceuticals, Inc. |
Methods and compositions for treatment of CNS disorders
|
US8673352B2
(en)
|
2005-04-15 |
2014-03-18 |
Mcneil-Ppc, Inc. |
Modified release dosage form
|
AU2006239838A1
(en)
*
|
2005-04-25 |
2006-11-02 |
Teva Pharmaceuticals Usa, Inc. |
Extended release formulations
|
US20060252745A1
(en)
|
2005-05-06 |
2006-11-09 |
Almeida Jose L D |
Methods of preparing pharmaceutical compositions comprising eslicarbazepine acetate and methods of use
|
US20070071819A1
(en)
*
|
2005-05-30 |
2007-03-29 |
Kesarwani Amit K |
Multiple unit modified release compositions of carbamazepine and process for their preparation
|
US7994220B2
(en)
*
|
2005-09-28 |
2011-08-09 |
Cypress Bioscience, Inc. |
Milnacipran for the long-term treatment of fibromyalgia syndrome
|
US20070077300A1
(en)
|
2005-09-30 |
2007-04-05 |
Wynn David W |
Oral compositions containing a salivation inducing agent
|
US8440695B2
(en)
*
|
2005-11-09 |
2013-05-14 |
St Jude Children's Research Hospital |
Use of chloroquine to treat metabolic syndrome
|
EP1998748B1
(en)
|
2006-03-16 |
2015-01-14 |
NicoNovum AB |
Improved snuff composition
|
WO2007112579A1
(en)
*
|
2006-04-03 |
2007-10-11 |
Isa Odidi |
Drug delivery composition
|
WO2007122635A2
(en)
*
|
2006-04-26 |
2007-11-01 |
Astron Research Limited |
Controlled release formulation comprising anti-epileptic drugs
|
WO2007127630A1
(en)
*
|
2006-04-26 |
2007-11-08 |
Supernus Pharmaceuticals, Inc |
Controlled released preparations of oxcarbazepine having sigmoidal release profile
|
AU2013200237B2
(en)
*
|
2006-04-26 |
2015-07-16 |
Supernus Pharmaceuticals, Inc. |
Controlled released preparations of oxcarbazepine having sigmoidal release profile
|
US8124598B2
(en)
*
|
2006-09-14 |
2012-02-28 |
Sharon Sageman |
7-keto DHEA for psychiatric use
|
BRPI0716995A2
(pt)
*
|
2006-09-27 |
2013-10-15 |
Niconovum Ab |
Métodos para administração oral de um líquido, e para aplicação de gotículas líquidas ou líquido atomizado contendo uma substância ativa no interior da boca de um indivíduo, dispositivo de pulverização, uso de um líquido, kit, e, uso de um kit
|
KR20090094076A
(ko)
*
|
2006-10-20 |
2009-09-03 |
맥네일-피피씨, 인코포레이티드 |
아세트아미노펜/이부프로펜 병용물
|
US7731604B2
(en)
*
|
2006-10-31 |
2010-06-08 |
Taylor Made Golf Company, Inc. |
Golf club iron head
|
JP5489719B2
(ja)
|
2006-11-17 |
2014-05-14 |
スパーナス ファーマシューティカルズ インコーポレイテッド |
トピラマートの徐放性配合物
|
US20080317678A1
(en)
*
|
2007-06-22 |
2008-12-25 |
Szymczak Christopher E |
Laser Marked Dosage Forms
|
US20080317677A1
(en)
*
|
2007-06-22 |
2008-12-25 |
Szymczak Christopher E |
Laser Marked Dosage Forms
|
US20090060983A1
(en)
*
|
2007-08-30 |
2009-03-05 |
Bunick Frank J |
Method And Composition For Making An Orally Disintegrating Dosage Form
|
US20100160274A1
(en)
*
|
2007-09-07 |
2010-06-24 |
Sharon Sageman |
7-KETO DHEA for Psychiatric Use
|
US20110091566A1
(en)
*
|
2007-09-25 |
2011-04-21 |
Nirmal Mulye |
Controlled release pharmaceutical compositions
|
US8372431B2
(en)
|
2007-10-26 |
2013-02-12 |
Bial-Portela & C.A., S.A. |
Pharmaceutical composition comprising licarbazepine acetate
|
MX2010004897A
(es)
*
|
2007-10-31 |
2010-05-19 |
Mcneil Ppc Inc |
Forma de dosificacion oralmente desintegrada.
|
US20090143362A1
(en)
*
|
2007-12-04 |
2009-06-04 |
Barabde Umesh Vinayakrao |
Carbamazepine formulations
|
CN101917975B
(zh)
*
|
2007-12-21 |
2013-05-08 |
麦克内尔-Ppc股份有限公司 |
片剂的制造
|
US20100285119A1
(en)
*
|
2008-01-11 |
2010-11-11 |
Jubilant Organosys Ltd. |
Multiparticulate Extended Release Pharmaceutical Composition Of Carbamazepine And Process For Manufacturing The Same
|
RU2011102777A
(ru)
*
|
2008-06-26 |
2012-08-10 |
МакНЕЙЛ-ППС, ИНК. (US) |
Частицы с покрытием, содержащие фармацевтически активные агенты
|
WO2010015029A1
(en)
|
2008-08-06 |
2010-02-11 |
Gosforth Centre (Holdings) Pty Ltd |
Compositions and methods for treating psychiatric disorders
|
US8833378B2
(en)
*
|
2008-09-17 |
2014-09-16 |
Niconovum Ab |
Process for preparing snuff composition
|
US20100233259A1
(en)
*
|
2008-12-12 |
2010-09-16 |
Pascal Grenier |
Dosage form of ropinirole
|
US8313768B2
(en)
|
2009-09-24 |
2012-11-20 |
Mcneil-Ppc, Inc. |
Manufacture of tablet having immediate release region and sustained release region
|
US20110070286A1
(en)
*
|
2009-09-24 |
2011-03-24 |
Andreas Hugerth |
Process for the manufacture of nicotine-comprising chewing gum and nicotine-comprising chewing gum manufactured according to said process
|
US8871263B2
(en)
|
2009-09-24 |
2014-10-28 |
Mcneil-Ppc, Inc. |
Manufacture of tablet in a die utilizing radiofrequency energy and meltable binder
|
US8858210B2
(en)
|
2009-09-24 |
2014-10-14 |
Mcneil-Ppc, Inc. |
Manufacture of variable density dosage forms utilizing radiofrequency energy
|
CN106389381A
(zh)
*
|
2009-12-02 |
2017-02-15 |
阿达玛斯医药公司 |
金刚烷胺组合物及其使用方法
|
GB201111712D0
(en)
|
2011-07-08 |
2011-08-24 |
Gosforth Ct Holdings Pty Ltd |
Pharmaceutical compositions
|
US20140302138A1
(en)
*
|
2011-10-14 |
2014-10-09 |
Micro Labs Limited |
Extended release pharmaceutical compositions containing carbamazepine
|
US9511028B2
(en)
|
2012-05-01 |
2016-12-06 |
Johnson & Johnson Consumer Inc. |
Orally disintegrating tablet
|
US9233491B2
(en)
|
2012-05-01 |
2016-01-12 |
Johnson & Johnson Consumer Inc. |
Machine for production of solid dosage forms
|
US9445971B2
(en)
|
2012-05-01 |
2016-09-20 |
Johnson & Johnson Consumer Inc. |
Method of manufacturing solid dosage form
|
US8999393B1
(en)
|
2013-01-09 |
2015-04-07 |
Edgemont Pharmaceuticals Llc |
Sustained release formulations of lorazepam
|
WO2014204933A1
(en)
|
2013-06-17 |
2014-12-24 |
Adamas Pharmaceuticals, Inc. |
Amantadine compositions and methods of use
|
WO2015073736A1
(en)
|
2013-11-13 |
2015-05-21 |
Arbor Pharmaceuticals, Llc |
Methods and compositions for treating adhd
|
ES2750323T3
(es)
|
2014-01-10 |
2020-03-25 |
Johnson & Johnson Consumer Inc |
Método para la fabricación de un comprimido mediante radiofrecuencia y partículas recubiertas con pérdida
|
CA3018328A1
(en)
|
2014-10-31 |
2016-04-30 |
Purdue Pharma |
Methods and compositions particularly for treatment of attention deficit disorder
|
WO2017004526A1
(en)
|
2015-07-02 |
2017-01-05 |
University Of Louisville Research Foundation, Inc. |
EDIBLE PLANT-DERIVED MICROVESICLE COMPOSITIONS FOR DELIVERY OF miRNA AND METHODS FOR TREATMENT OF CANCER
|
US10973783B2
(en)
|
2015-12-30 |
2021-04-13 |
Adamas Pharmaceuticals, Inc. |
Methods and compositions for the treatment of seizure-related disorders
|
US10493026B2
(en)
|
2017-03-20 |
2019-12-03 |
Johnson & Johnson Consumer Inc. |
Process for making tablet using radiofrequency and lossy coated particles
|
WO2018200885A1
(en)
|
2017-04-26 |
2018-11-01 |
Neurocentria, Inc. |
Magnesium compositions and methods of use
|
JP7273976B2
(ja)
*
|
2018-09-21 |
2023-05-15 |
アムニール コンプレックス プロダクツ リサーチ エルエルシー |
トリヘキシフェニジルを含む徐放性組成物
|
US10722473B2
(en)
|
2018-11-19 |
2020-07-28 |
Purdue Pharma L.P. |
Methods and compositions particularly for treatment of attention deficit disorder
|